Prevention of mother-to-child transmission of HIV: A simple and highly efficacious regimen;Prévention de la transmission mère-enfant du VIH: Un protocole simple, d'une efficacité remarquable

Medecine/Sciences

Volumn 21, Issue 1, 2005, Pages 28-29

  Lallemant, Marc ^a,b   Jourdain, Gonzague ^b   Cœur, Sophie Le ^c   Ngo Giang Huong, Nicole ^b   Thaineua, Vallop ^d  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^d Min de la Santé Publique   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; ZIDOVUDINE;

CLINICAL TRIAL; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; NOTE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; RISK ASSESSMENT; THAILAND;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 12344278404     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200521128     Document Type: Note

References (4)

1. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996; 335: 1621-9.
2. Jourdain G, Ngo-Giang-Huong N, Le Coeur S, et al. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004; 351: 229-40.
3. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. Genève: OMS, 2004: 50 p. http://www.who.int/3by5/arv_pmtct/en/.
4. e Conférence Internationale sur le Sida, juillet 2004, Lb0rB09.